Literature DB >> 20802467

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease.

Cristina Magi-Galluzzi1, Andrew J Evans, Brett Delahunt, Jonathan I Epstein, David F Griffiths, Theo H van der Kwast, Rodolfo Montironi, Thomas M Wheeler, John R Srigley, Lars L Egevad, Peter A Humphrey.   

Abstract

The International Society of Urological Pathology Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens in Boston made recommendations regarding the standardization of pathology reporting of radical prostatectomy specimens. Issues relating to extraprostatic extension (pT3a disease), bladder neck invasion, lymphovascular invasion and the definition of pT4 were coordinated by working group 3. It was agreed that prostate cancer can be categorized as pT3a in the absence of adipose tissue involvement when cancer bulges beyond the contour of the gland or beyond the condensed smooth muscle of the prostate at posterior and posterolateral sites. Extraprostatic extension can also be identified anteriorly. It was agreed that the location of extraprostatic extension should be reported. Although there was consensus that the amount of extraprostatic extension should be quantitated, there was no agreement as to which method of quantitation should be employed. There was overwhelming consensus that microscopic urinary bladder neck invasion by carcinoma should be reported as stage pT3a and that lymphovascular invasion by carcinoma should be reported. It is recommended that these elements are considered in the development of practice guidelines and in the daily practice of urological surgical pathology.

Entities:  

Mesh:

Year:  2010        PMID: 20802467     DOI: 10.1038/modpathol.2010.158

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  38 in total

Review 1.  [Diagnostics of radical prostatectomy specimens. Results of the 2009 consensus conference of the International Society of Urological Pathology].

Authors:  G Kristiansen; J R Srigley; B Delahunt; L Egevad
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

2.  Preoperative Prediction of Extracapsular Extension: Radiomics Signature Based on Magnetic Resonance Imaging to Stage Prostate Cancer.

Authors:  Shuai Ma; Huihui Xie; Huihui Wang; Jiejin Yang; Chao Han; Xiaoying Wang; Xiaodong Zhang
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

3.  Impact of the extent of extraprostatic extension defined by Epstein's method in patients with negative surgical margins and negative lymph node invasion.

Authors:  T Maubon; N Branger; C Bastide; G Lonjon; K-A Harvey-Bryan; P Validire; S Giusiano; D Rossi; X Cathelineau; F Rozet
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-12       Impact factor: 5.554

4.  Re-evaluating the concept of "dominant/index tumor nodule" in multifocal prostate cancer.

Authors:  Cheng Cheng Huang; Fang-Ming Deng; Max X Kong; Qinhu Ren; Jonathan Melamed; Ming Zhou
Journal:  Virchows Arch       Date:  2014-03-12       Impact factor: 4.064

5.  Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples.

Authors:  Metka Volavšek; Vanessa Henriques; Ana Blanca; Rodolfo Montironi; Liang Cheng; Maria R Raspollini; Alessia Cimadamore; Nuno Vau; Francesco Pierconti; Antonio Lopez-Beltran
Journal:  Virchows Arch       Date:  2019-10-07       Impact factor: 4.064

Review 6.  Histopathology of Prostate Cancer.

Authors:  Peter A Humphrey
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

Review 7.  Synergistic action of image-guided radiotherapy and androgen deprivation therapy.

Authors:  Jennifer A Locke; Alan Dal Pra; Stéphane Supiot; Padraig Warde; Robert G Bristow
Journal:  Nat Rev Urol       Date:  2015-03-24       Impact factor: 14.432

8.  Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline.

Authors:  Jennifer Salerno; Antonio Finelli; Chris Morash; Scott C Morgan; Nicholas Power; Nichola Schieda; Masoom A Haider
Journal:  Can Urol Assoc J       Date:  2016-10-13       Impact factor: 1.862

Review 9.  The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Authors:  Matteo Ferro; Daniela Terracciano; Carlo Buonerba; Giuseppe Lucarelli; Danilo Bottero; Sisto Perdonà; Riccardo Autorino; Alessandro Serino; Francesco Cantiello; Rocco Damiano; Iulia Andras; Sabino De Placido; Giuseppe Di Lorenzo; Michele Battaglia; Barbara A Jereczek-Fossa; Vincenzo Mirone; Ottavio De Cobelli
Journal:  Future Oncol       Date:  2016-09-14       Impact factor: 3.404

10.  Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer.

Authors:  Hyungwoo Ahn; Sung Il Hwang; Hak Jong Lee; Hyoung Sim Suh; Gheeyoung Choe; Seok-Soo Byun; Sung Kyu Hong; Sangchul Lee; Joongyub Lee
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.